Article | Open | Published:

Bmi1-positive cells in the lingual epithelium could serve as cancer stem cells in tongue cancer

Scientific Reports volume 6, Article number: 39386 (2016) | Download Citation


We recently reported that the polycomb complex protein Bmi1 is a marker for lingual epithelial stem cells (LESCs), which are involved in the long-term maintenance of lingual epithelial tissue in the physiological state. However, the precise role of LESCs in generating tongue tumors and Bmi1-positive cell lineage dynamics in tongue cancers are unclear. Here, using a mouse model of chemically (4-nitroquinoline-1-oxide: 4-NQO) induced tongue cancer and the multicolor lineage tracing method, we found that each unit of the tumor was generated by a single cell and that the assembly of such cells formed a polyclonal tumor. Although many Bmi1-positive cells within the tongue cancer specimens failed to proliferate, some proliferated continuously and supplied tumor cells to the surrounding area. This process eventually led to the formation of areas derived from single cells after 1–3 months, as determined using the multicolor lineage tracing method, indicating that such cells could serve as cancer stem cells. These results indicate that LESCs could serve as the origin for tongue cancer and that cancer stem cells are present in tongue tumors.


Although lingual epithelial tissue is thought to be the origin of squamous cell carcinoma of the tongue, little is known about the cell types involved in tumorigenesis and whether cancer stem cells exist within the tumor. There are approximately 600,000 new cases of head and neck squamous cell carcinomas (HNSCCs) annually worldwide. HNSCCs usually develop in the oral cavity, oropharynx, larynx, or hypopharynx. Oral cancers are among the most common cancers, accounting for approximately 3% of all malignant tumors in both sexes1,2. Of these, tongue squamous cell carcinoma is highly aggressive, particularly when it occurs in young patients, and is often diagnosed in the advanced stages (stages III–IV), associated with a high metastasis rate and poor prognosis3,4. Because the 5-year survival rate has not improved substantially in the past 20 years for patients with tongue squamous cell carcinoma, it is important to elucidate the mechanism underlying tumorigenesis and tumor growth and to identify novel cancer stem cell markers for the development of new molecular-targeted therapies5.

Many studies have reported heterogeneity in the generation of human cancers and the existence of cancer stem cells that may explain resistance to radiological and chemical therapies6,7. For example, using mouse models, squamous cell carcinoma8 and pancreatic ductal carcinoma9 were shown to be heterogeneous. However, the strict verification of cancer stem cells in vivo is still necessary. We recently reported that Bmi1-positive cells are involved in the long-term maintenance of the lingual epithelium in the physiological state and quickly repair the lingual epithelium after irradiation-induced injury10,11. However, it is not known whether these cells serve as tongue cancer stem cells. In this study, we adopted the multicolor lineage tracing method to analyze the role of Bmi1-positive cells in a mouse model of chemically induced tongue cancer.


Histological features of chemically induced tongue cancer

4-NQO induces carcinomas in the oral cavities of mice12,13. In the current study, mice were administered 4-NQO (Fig. 1a) and more than 80% developed tongue cancers as well as esophageal cancers (Fig. 1b, Table 1). The tongues of 4-NQO-treated mice exhibited focal thickness and the lingual epithelium lacked organization (Fig. 1d), whereas the majority of the normal tongue epithelium was covered with aligned filiform papillae (Fig. 1c). We also observed both papillary or neoplastic squamous lesions (papillomas or carcinoma in situ) and invasive SCCs, identified by the invasion of neoplastic epithelial cells into the subepithelial tissues (Fig. 1d). Although cytokeratin-14 (Krt14) was specifically expressed in the basal layer of the normal lingual epithelium (Supplementary Fig. 1a), cancerous lesions lost this polarity, and Krt14 was uniformly expressed (Fig. 1e: left). In addition, the number of Ki67-positive cells was higher than that in the normal tongue epithelium (Fig. 1e: right, Supplementary Fig. 1b).

Figure 1: Morphological observations of tongue cancer and histological analysis of normal tongue and tongue cancer model.
Figure 1

(a) Schematic representation of the timing of 4-NQO administration. (b) Morphological observations of normal tongues and tongues of cancer model mice. The red arrow indicates papilloma. The blue arrow indicates invasive carcinoma. (c) H&E staining of normal tongues and the filiform papillae (d) H&E staining of tongue cancer (e) Immunohistochemical staining of tongue cancer for Krt14 and Ki67. Scale bars: (b) 1 mm; (c) 1 mm (left), 100 μm (right); (d) 1 mm (left), 100 μm (right) (e) 100 μm.

Table 1: 4-NQO induction of tongue cancer in C57BL/6, Bmi1creER/+/Rosa26rbw/+ mice, and Rosa26CreERT2/rbw mice.

Clonal analysis of the origin of tongue cancer

To determine if the origin of 4-NQO-induced tongue tumors is monoclonal, we labeled all epithelial cells with random colors and followed their fates in Rosa26CreERT2/rbw mice14,15,16. Compared with conventional lineage tracing methods17, this system enables the clonal origin of tumors to be visualized and each cell cluster in the tumor derived from different clones could be easily distinguished based on color, as previously reported11,16,18,19,20. Using this system, we recently found that in the normal lingual epithelium, long-term stem cells are located in the interpapillary pit (IPP)11. The stem cells continuously self-renew and produce cells such that, at 4 weeks after labeling, the IPP area is occupied by single-colored cells, all of which are derived from a single stem cell. To determine the number of such cell clusters present in tongue tumors and to examine the clonal origin of these tumors, we labeled all cells of the tongue before inducing carcinogenesis by 4-NQO (Supplementary Fig. 2a). The IPPs in noncancerous tongue lesions in 4-NQO-treated mice showed focal thickness (hyperplasia) and were segmented into single-colored areas as well as normal lingual epithelia (Supplementary Fig. 2b). Both neoplastic squamous lesions (carcinoma in situ) (Supplementary Fig. 2c,d) and invasive SSCs (invasive carcinoma) (Supplementary Fig. 2e) were composed of several cell clusters. Taken together, these results suggest that each unit of the tumor was generated by a single cell, the assembly of which led to the formation of a polyclonal tumor.

Presence of cancer stem cells in developing tongue cancers

We checked for the presence of cancer stem cells in developing tumors using the multicolor lineage tracing method. Carcinogenesis was induced in RosacreERT2/rbw mice, and tamoxifen injection was used to label all cells in the lingual epithelium (Fig. 2a,b). At 1 day after tamoxifen induction, the tumor cells were found to be randomly labeled (Fig. 2b). At day 7, several patches, each of which consisted of single-colored cells, were found in the tongue papilloma and carcinoma, indicating that certain cells in tongue cancer continuously proliferated and supplied tumor cells to the surrounding area (Fig. 2c). These results suggested that tongue cancer stem cells were present in the developing tumor.

Figure 2: Rosa26CreERT2/rbw mice were labeled with tamoxifen and induced by 4-NQO after the induction of tongue cancer.
Figure 2

Schematic representation of the outcome of multi-color lineage tracing in the Rosa26CreERT2/+ tongue cancer model and timing of 4–NQO and tamoxifen treatment. (b,c) Rosa26CreERT2/rbw mice were injected with tamoxifen after inducing tongue cancer and analyzed at the indicated time points (day 1 and day 7). Scale bars: (b) 50 μm (right), 100 μm (left); (c) 50 μm (right), 100 μm (left and middle).

Bmi1-positive cells could serve as cancer stem cells

To determine whether Bmi1-positive cells in tongue cancer serve as cancer stem cells, we used the gene-specific multicolor lineage tracing method to test if Bmi1-positive cells form patches in mice with tongue cancer as well as in RosacreERT2/rbw mice (Fig. 2c). To this end, after tumor induction by 4-NQO in Bmi1creER/+/Rosa26rbw/+ mice, the Bmi1-positive cells in the resultant tumors were labeled with tamoxifen and analyzed at various time points (Fig. 3a). The initial observation at day 7 after labeling revealed that Bmi1-positive cells were scattered in the developing tumors (Fig. 3b). Some of these cells then proliferated to form patches, which could be observed at 2–4 weeks after tamoxifen induction (Fig. 3c,d), demonstrating their continuous proliferation and supply of tumor cells. Although the tracing period was limited to 4 weeks owing to mouse death, the results indicate that at least some Bmi1-positive cells could serve as cancer stem cells, aiding the long-term maintenance of developing tumors. The number of Bmi1-positive cells that remained as single cells gradually decreased in the tongue tumors (Fig. 3e), suggesting that Bmi1 was also expressed in differentiated cells, which could neither self-renew nor supply tumor cells; the cells underwent terminal differentiation and finally disappeared.

Figure 3: Fate of cells derived from Bmi1-positive cells in tongue cancer.
Figure 3

(a) Schematic representation of the outcome of multi-color lineage tracing in the Bmi1creER/+/Rosa26rbw/+ tongue cancer model. (b,c,d) Bmi1creER/+/Rosa26rbw/+ mice were injected with tamoxifen and analyzed at the indicated time points (day 7, day 14, and day 28). (e) The ratio of single Bmi1-positive cells in the tumor (Bmi1creER/+/Rosa26rbw/+ mice, N = 6; day 7: n = 39 clones, day 14: n = 29 clones, day 28: n = 123 clones). *p < 0.01. Scale bars: (b) 50 μm (left), 100 μm (right); (c) 50 μm (left), 100 μm (right); (d) 100 μm.


To prevent carcinogenesis and treat cancer, it is extremely important to identify the origin of the cancer. In our study, carcinoma in situ or invasive SSC was composed of several cell clusters, each of which was derived from a different clone. By labeling Bmi1+ cells in Bmi1creER/+/Rosa26rbw/+ mice prior to inducing carcinogenesis, we examined whether tongue cancer originated from Bmi1+ LESCs. However, we could not detect single-colored tumors, i.e., monoclonal tumors, even 24 weeks after carcinogenesis induction (data not shown).

Although these results indicate that tongue cancer was polyclonal, they do not suggest a polyclonal origin. Rather, a better explanation for the observation that a single tumor was clearly segmented is that each unit of the tumor was generated from a single cell and multiple monoclonal tumors simultaneously developed and aggregated. This was probably because the method randomly induces multiple cancers and is therefore not appropriate for investigations of specific cells, such as Bmi1+ tongue stem cells, in tumor generation. We also analyzed Bmi1CreERT/+/Rosa26lsl-KrasG12D/rbw mice in which the KrasG12D mutation was induced in Bmi1-positive cells by tamoxifen, we could not detect any tumors in the tongue nor the oral mucosa. It may be useful to attempt to induce additional mutations, such as p53 or PTEN mutations.

We found that Bmi1+ cells produced clusters of single-colored cells in developing tumors, suggesting that Bmi1+ tumorigenic cells behaved as cancer stem cells and continually provided transit-amplifying cells in tongue tumors, contributing to tumor growth. In the same experiment, Bmi1+ cells that remained as single cells were also observed in the tumors at 28 days after labeling. One possibility is that they were differentiated cells, and could not proliferate further. Although immunostaining of rainbow colored-tumors to detect Ki67-positive cells might be helpful to distinguish fast-cycling cells, slow-cycling cells, and differentiated cells, this was unfortunately not possible owing to technical limitations. Co-staining of Ki67 is also helpful to distinguish between trans-amplifying cells and differentiated cells, but is not technically viable in this multicolor model. Another possibility is that they were resting cancer stem cells. In the physiological state, differentiated and labeled Bmi1+ cells in the lingual epithelium of Bmi1creER/+/Rosa26rbw/+ mice were terminally differentiated and disappeared within 7 days after labeling (data not shown). Furthermore, we did not observe Bmi1+ LESCs that remained in the resting state for more than 28 days. This could be attributed to the tumor environment surrounding these cells or their newly acquired characteristics after canceration. We could not determine which of these two possibilities was applicable to the resting Bmi1+ tumor cells, mainly because the mice with tongue tumors did not survive for a sufficiently long period.

The molecular mechanisms that underlie the regulation of tongue cancer stem cells by Bmi1 need to be investigated. It has been reported that Bmi1+ cells in pancreatic adenocarcinomas can self-regenerate21,22. Bmi1 is also associated with cancer stem cell markers, such as CD44 and Sox223,24. Another study has also suggested that Bmi1 could serve as a molecular target for tongue cancer treatment, as Bmi1 overexpression is associated with invasion and poor prognosis in tongue squamous cell carcinoma25. Downregulation of Bmi1 with a small molecule, such as PTC 209 (N-(2,6-dibromo-4-methoxyphenyl)-4-(2-methylimidazo[1,2-a]pyrimidin-3-yl)-2-thiazolamine), inhibits the tumorigenic potential in colorectal cancer26. It is important to determine whether this molecule is also effective in tongue cancer.

Thus, we propose that at least some Bmi1+ tumorigenic cells behave as tongue cancer stem cells in developing tumors. Further studies are required to clarify the relationship between these cancer stem cells and Bmi1+ LESCs and to identify the cells of origin in tongue cancer.



Mice were bred and maintained at the Kansai Medical University Research Animal Facility in accordance with the Kansai Medical University guidelines. C57BL/6 J, Bmi1CreER/+27, Rosa26CreERT2/+, and Rosa26rbw/+ mice were purchased from Jackson Laboratories (Sacramento, CA, USA) or generated as previously described15,16,17. The experiments were approved by the Kansai Medical University Welfare Committee. Tamoxifen (Sigma, St. Louis, MO, USA) was dissolved in corn oil (Sigma) and intraperitoneally injected into adult mice at concentrations of 9 and 5 mg/40 g body weight for Bmi1CreER/+ mice and Rosa26CreERT2/+ mice, respectively.

Chemically induced tongue tumors

4-Nitroquinoline-1-oxide (4-NQO) (Wako Pure Chemical Industries, Osaka, Japan) stock solution was diluted (final concentration, 100 μg/ml) in drinking water and administered to seven C57BL/6 mice, six Bmi1creER/+/Rosa26rbw/+ mice, and seven Rosa26CreERT2/rbw mice. Starting from 16 weeks, the benign or malignant tumors that developed in the oral cavity and tongue were analyzed at various time points up to 28 weeks.

Histological analyses

Mice were sacrificed, and the tissues were fixed, frozen, cut, and analyzed as previously reported11,18,19. Immunostaining was performed using the primary antibodies Ki67 (1:50; Dako, Glostrup, Denmark), cytokeratin 14 (Krt14, 1:2000; Covance, NJ, USA), and peroxidase- (1:200; Invitrogen, Carlsbad, CA, USA) as described previously11. Hematoxylin and eosin staining was performed using a standard protocol.

Statistical analysis

The ratio of the single Bmi1-positive cells to the number of Bmi1-positive clusters was assessed in a section of the tongue tumor from six Bmi1creER/+/Rosa26rbw/+ mice in which tumorigenesis was induced by 4-NQO. Day 7: n = 39 clones, mean 36.48, s.d. 13.46; day 14: n = 29 clones, mean 28.18, s.d. 6.17; day 28: n = 123 clones, mean 8.33, s.d. 1.15.

Ethics statement

All animal experiments were performed in accordance with the Kansai Medical University guidelines and were approved by the Kansai Medical University Animal Experiment Committee.

Additional Information

How to cite this article: Tanaka, T. et al. Bmi1-positive cells in the lingual epithelium could serve as cancer stem cells in tongue cancer. Sci. Rep. 6, 39386; doi: 10.1038/srep39386 (2016).

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


  1. 1.

    , & Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24, 2137–2150 (2006).

  2. 2.

    , & The molecular biology of head and neck cancer. Nat Rev Cancer 11, 9–22 (2011).

  3. 3.

    et al. Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a review. Clin Otolaryngol 32, 337–345 (2007).

  4. 4.

    Oral cancer prevention and control–the approach of the World Health Organization. Oral Oncol 45, 454–460 (2009).

  5. 5.

    , & Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome. Cancer 118, 101–111 (2012).

  6. 6.

    & Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).

  7. 7.

    , , & The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501, 338–345 (2013).

  8. 8.

    , & TGF-beta promotes heterogeneity and drug resistance in squamous cell carcinoma. Cell 160, 963–976 (2015).

  9. 9.

    & Pancreatic cancer metastases harbor evidence of polyclonality. Cancer Discov 5, 1086–1097 (2015).

  10. 10.

    et al. Establishment of a novel lingual organoid culture system: generation of organoids having mature keratinized epithelium from adult epithelial stem cells. Sci Rep 3, 3224 (2013).

  11. 11.

    et al. Identification of stem cells that maintain and regenerate lingual keratinized epithelial cells. Nat Cell Biol 15, 511–518 (2013).

  12. 12.

    et al. 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma. Head Neck 16, 424–432 (1994).

  13. 13.

    , , , & Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res 10, 301–313 (2004).

  14. 14.

    et al. Experimental evidence showing that no mitotically active female germline progenitors exist in postnatal mouse ovaries. Proc Natl Acad Sci USA 109, 12580–12585 (2012).

  15. 15.

    , , , & Germ-layer and lineage-restricted stem/progenitors regenerate the mouse digit tip. Nature 476, 409–413 (2011).

  16. 16.

    , , & Coronary arteries form by developmental reprogramming of venous cells. Nature 464, 549–553 (2010).

  17. 17.

    Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21, 70–71 (1999).

  18. 18.

    , & Two-step oligoclonal development of male germ cells. Proc Natl Acad Sci USA 106, 175–180 (2009).

  19. 19.

    & The origin and fate of yolk sac hematopoiesis: application of chimera analyses to developmental studies. Int J Dev Biol 54, 1019–1031 (2010).

  20. 20.

    & Clonal analysis of mouse development reveals a polyclonal origin for yolk sac blood islands. Dev Cell 11, 519–533 (2006).

  21. 21.

    , , & Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell 7, 682–693 (2010).

  22. 22.

    et al. Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma. PLoS One 8, e55820 (2013).

  23. 23.

    , , , & Distinct functions of Sox2 control self-renewal and differentiation in the osteoblast lineage. Mol Cell Biol 31, 4593–4608 (2011).

  24. 24.

    , , , & Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis. J Oral Pathol Med 43, 492–498 (2014).

  25. 25.

    et al. Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma. Int J Biol Sci 11, 1–10 (2015).

  26. 26.

    et al. Self-renewal as a therapeutic target in human colorectal cancer. Nat Med 20, 29–36 (2014).

  27. 27.

    & Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 40, 915–920 (2008).

Download references


The authors thank N. Nishida for animal care and technical assistance. TT was Research Fellow of Japan Society for the Promotion of Science. The authors acknowledge financial support from the following sources: Funding Program for Next Generation World-Leading Researchers, Grant-in-Aid for Scientific Research(A), Grant-in-Aid for Challenging Exploratory Research, The Mochida Memorial Foundation, The Naito Memorial Foundation, The Cell Science Research Foundation, The Uehara Memorial Foundation, The Mitsubishi Foundation, The Yasuda Memorial Foundation, The Takeda Science Foundation, The Research Foundation for Opto-Science and Technology, The Princess Takamatsu Cancer Research Fund and CREST, JST to H.U.

Author information


  1. Department of Stem Cell Pathology, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka 573-1010, Japan

    • Toshihiro Tanaka
    • , Naho Atsumi
    • , Naohiro Nakamura
    • , Hirotsugu Yanai
    • , Yoshihiro Komai
    • , Taichi Omachi
    • , Kiyomichi Tanaka
    • , Kazuhiko Ishigaki
    • , Kazuho Saiga
    • , Haruyuki Ohsugi
    • , Yoko Tokuyama
    • , Yuki Imahashi
    • , Hiroko Hisha
    • , Naoko Yoshida
    • , Keiki Kumano
    •  & Hiroo Ueno
  2. Third Department of Internal Medicine, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka 573-1010, Japan

    • Toshihiro Tanaka
    •  & Kazuichi Okazaki
  3. Department of Surgery, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka 573-1010, Japan

    • Toshihiro Tanaka
    •  & Naohiro Nakamura
  4. Department of Urology and Andrology, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka 573-1010, Japan

    • Hirotsugu Yanai
  5. Department of Pediatrics, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka 573-1010, Japan

    • Yoshihiro Komai
    •  & Haruyuki Ohsugi


  1. Search for Toshihiro Tanaka in:

  2. Search for Naho Atsumi in:

  3. Search for Naohiro Nakamura in:

  4. Search for Hirotsugu Yanai in:

  5. Search for Yoshihiro Komai in:

  6. Search for Taichi Omachi in:

  7. Search for Kiyomichi Tanaka in:

  8. Search for Kazuhiko Ishigaki in:

  9. Search for Kazuho Saiga in:

  10. Search for Haruyuki Ohsugi in:

  11. Search for Yoko Tokuyama in:

  12. Search for Yuki Imahashi in:

  13. Search for Hiroko Hisha in:

  14. Search for Naoko Yoshida in:

  15. Search for Keiki Kumano in:

  16. Search for Kazuichi Okazaki in:

  17. Search for Hiroo Ueno in:


T.T. mainly performed the experiments. H.U. supervised the experiments. N.A., N.N., H.Y., Y.K., T.O., K.T., K.I., K.S., H.O., Y.T., Y.I., H.H., N.Y., K.K., K.O. and H.U. performed parts of experiments. T.T., N.A. and H.U. wrote the manuscript.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Hiroo Ueno.

Supplementary information

About this article

Publication history






By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.